The Home of Accelerating Microbiome R&D

R&D
The Home of Accelerating Microbiome R&D

Celebrating its 10th anniversary, the Microbiome Movement USA Summit will reunite the community with perspectives from 140+ Microbiome R&D experts from experts from pharma, biotech, regulatory bodies and investors. Enjoy 2 tracks dedicated to showcasing the latest scientific evidence for GI, Infectious Disease, Gut-Brain Axis, Dermatology, Pulmonary, Female Health, and more for a breakthrough in demonstrating efficacy and securing funding for 2025.

With 2024 alone welcoming Freya Bio’s $10 mill investment, Kanvas Bio unveiling new clinical data on antitumoral immunity impact, Enterobiotix advancing Cirrhosis and Nexilico & Siolta Tx collaboration for necrotizing enterocolitis there’s been a lot of movement in the field. Despite funding challenges in the past few years, as microbiome awareness increases and new preclinical and clinical data emerges, the microbiome community remains committed to proving the microbiome potential to treat patients across many therapeutic areas.  

Including representatives from Pulmobiotics, Seres Therapeutics, BiomeBank, and PharmaBiome, engage in dynamic discussions, forge valuable partnerships, and gain actionable insights that will drive your microbiome research and development forward.;

What will you look forward to this year?

  • 18+ new presenting companies (including Mbiomics, KeepBio, Florey Biosciences, Azitra, Novartis and Daré Biosciences) and 24+ fresh faces taking the stage to share their expertise as part of our 35+ speaker line-up
  • 8+ hours of networking including speed networking, the first ever 10th anniversary Microbiome Awards and drinks reception, and the Startup Showcase where you can apply to pitch your innovative research, technology, expert team and commercial strategy in front of a panel of world-class microbiome VCs and investors
  • 6 Scientific Advisory Board Members guiding the strategic and scientific direction of the 2025 agenda to ensure this year is in line with the key priorities of the field

Download the full 2025 Event Guide to learn more: https://ter.li/mr93ae

Who’s attending?

Discover the latest advancements from emerging companies like Alveolus Bio, Microviable Therapeutics, Unilever, Mikrobiomik, Jona, and Nestle Health Science, each presenting their innovative approaches in microbiome research.

Why do your peers love attending?

“Good mix of Microbiome companies working on different products to address various ailments.” - Thermo Fisher Scientific Microbiology Division

“A good mix of new data, interesting companies, and relevant service providers” -  Siolta Therapeutics

“Great speakers, great network of participants, great venue, great organization, and great mix of agenda tracks and formats.”  -  AOBiome

Don’t miss out on this great opportunity to be at the forefront of microbiome innovation and to collaborate with the brightest minds in the industry.

Book your place today: https://ter.li/gw9lw2

Image
Handsonwade